These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31020940)

  • 1. Bisphosphonates and Cancer: A Relationship Beyond the Antiresorptive Effects.
    Teixeira S; Branco L; Fernandes MH; Costa-Rodrigues J
    Mini Rev Med Chem; 2019; 19(12):988-998. PubMed ID: 31020940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis.
    Green JR; Clézardin P
    Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S3-9. PubMed ID: 12562045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity.
    Clézardin P; Ebetino FH; Fournier PG
    Cancer Res; 2005 Jun; 65(12):4971-4. PubMed ID: 15958534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemistry of bisphosphonates: from antiscaling agents to clinical therapeutics.
    Widler L; Jahnke W; Green JR
    Anticancer Agents Med Chem; 2012 Feb; 12(2):95-101. PubMed ID: 21864230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of bisphosphonates.
    Green JR
    Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor potential of bisphosphonates.
    Clézardin P
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates: preclinical review.
    Green JR
    Oncologist; 2004; 9 Suppl 4():3-13. PubMed ID: 15459425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of bisphosphonates to target bone cancer metastasis: an overview.
    Singh T; Kaur V; Kumar M; Kaur P; Murthy RS; Rawal RK
    J Drug Target; 2015 Jan; 23(1):1-15. PubMed ID: 25203856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages.
    Luckman SP; Coxon FP; Ebetino FH; Russell RG; Rogers MJ
    J Bone Miner Res; 1998 Nov; 13(11):1668-78. PubMed ID: 9797474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antitumor effects of bisphosphonates.
    Clézardin P; Fournier P; Boissier S; Peyruchaud O
    Curr Med Chem; 2003 Jan; 10(2):173-80. PubMed ID: 12570716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evidence for the effect of bisphosphonates and cytotoxic drugs on tumor cell invasion.
    Woodward JK; Coleman RE; Holen I
    Anticancer Drugs; 2005 Jan; 16(1):11-9. PubMed ID: 15613899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of bisphosphonate activity in vitro.
    Mitrofan LM; Auriola S; Mönkkönen H; Mönkkönen J
    Curr Pharm Des; 2010; 16(27):2970-80. PubMed ID: 20722618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrogen-containing bisphosphonates and cancer immunotherapy.
    Clézardin P; Massaia M
    Curr Pharm Des; 2010; 16(27):3007-2014. PubMed ID: 20722623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
    Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
    Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates and cancer.
    Milner RJ; Farese J; Henry CJ; Selting K; Fan TM; de Lorimier LP
    J Vet Intern Med; 2004; 18(5):597-604. PubMed ID: 15515572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential anticancer properties of bisphosphonates.
    Neville-Webbe HL; Gnant M; Coleman RE
    Semin Oncol; 2010 Jun; 37 Suppl 1():S53-65. PubMed ID: 20682373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
    Russell RG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH
    Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of bisphosphonates on breast cancer cells.
    Senaratne SG; Colston KW
    Breast Cancer Res; 2002; 4(1):18-23. PubMed ID: 11879555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
    Santini D; Vespasiani Gentilucci U; Vincenzi B; Picardi A; Vasaturo F; La Cesa A; Onori N; Scarpa S; Tonini G
    Ann Oncol; 2003 Oct; 14(10):1468-76. PubMed ID: 14504045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.